A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00829647
Recruitment Status : Withdrawn (Unable to enroll)
First Posted : January 27, 2009
Last Update Posted : July 19, 2017
Bristol-Myers Squibb
Celgene Corporation
Information provided by (Responsible Party):
Darren Sigal, MD, Scripps Health